Literature DB >> 12721292

A combinatorial G protein-coupled receptor reconstitution system on budded baculovirus. Evidence for Galpha and Galphao coupling to a human leukotriene B4 receptor.

Kazuyuki Masuda1, Hiroshi Itoh, Toshiko Sakihama, Chiyuki Akiyama, Kazuaki Takahashi, Rie Fukuda, Takehiko Yokomizo, Takao Shimizu, Tatsuhiko Kodama, Takao Hamakubo.   

Abstract

To investigate the coupling selectivity of G proteins and G protein-coupled receptors (GPCRs), we developed a reconstitution system made up of GPCR and heterotrimeric G proteins on extracellular baculovirus particles (budded virus (BV)). BV released from Sf9 cells infected with a recombinant baculovirus coding for human leukotriene B4 receptor (BLT1) cDNA exhibited a high level of BLT1 expression (27.3 pmol/mg of protein) and specific [3H]leukotriene B4 binding activity (Kd = 3.67 nm). The apparent low affinity of the expressed BLT1 is thought to be due to relative non-availability of the Galphai isoform, which couples to BLT1, in BV. Co-infection of heterotrimeric G protein recombinant viruses led to co-expression of BLT1 and G protein subunits on BV. A guanosine-5'-(beta,gamma-imido)triphosphate-sensitive, high affinity ligand binding was observed in the BLT1 BV co-expressing Galphai1beta1gamma2 (Kd = 0.17 nm). A relatively large amount of high affinity receptor protein was recovered in the co-expressing BV fraction (6.81 pmol/mg of protein). A combination of BLT1 and Galphai1 without Gbeta1gamma2 did not exhibit high affinity ligand binding on BV, indicating the low background environment for the GPCR-G protein coupling in this BV reconstitution system. To test other G proteins for coupling, various Galpha subunits were combinatorially expressed in BV with BLT1 and Gbeta1gamma2. The BLT1 BV co-expressing GalphaoAbeta1gamma2 exhibited a comparably high affinity ligand binding as well as ligand-stimulated guanosine 5'-3-O-(thio)triphosphate binding to Galphai1beta1gamma2. Co-expression of other Galpha isoforms such as Galphas, Galpha11, Galpha14, Galpha16, Galpha12, or Galpha13 did not exhibit any significant effects on ligand binding affinity in this system. These results reveal that BLT1 and coupled trimeric G proteins were functionally reconstituted on BV and that Galphao as well as Galphai couples to BLT1. This expression system should prove highly useful for pharmacological characterization, biosensor chip applications, and also drug discovery directed at highly important targets of the membrane receptor proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12721292     DOI: 10.1074/jbc.M302801200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Asymmetric conformational changes in a GPCR dimer controlled by G-proteins.

Authors:  Marjorie Damian; Aimée Martin; Danielle Mesnier; Jean-Philippe Pin; Jean-Louis Banères
Journal:  EMBO J       Date:  2006-11-30       Impact factor: 11.598

2.  Engineering a G protein-coupled receptor for structural studies: stabilization of the BLT1 receptor ground state.

Authors:  Aimée Martin; Marjorie Damian; Michel Laguerre; Joseph Parello; Bernard Pucci; Laurence Serre; Sophie Mary; Jacky Marie; Jean-Louis Banères
Journal:  Protein Sci       Date:  2009-04       Impact factor: 6.725

3.  Neutralization of the γ-secretase activity by monoclonal antibody against extracellular domain of nicastrin.

Authors:  I Hayashi; S Takatori; Y Urano; Y Miyake; J Takagi; M Sakata-Yanagimoto; H Iwanari; S Osawa; Y Morohashi; T Li; P C Wong; S Chiba; T Kodama; T Hamakubo; T Tomita; T Iwatsubo
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

4.  Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy.

Authors:  Norihiko Yokoi; Yuko Fukata; Daisuke Kase; Taisuke Miyazaki; Martine Jaegle; Toshika Ohkawa; Naoki Takahashi; Hiroko Iwanari; Yasuhiro Mochizuki; Takao Hamakubo; Keiji Imoto; Dies Meijer; Masahiko Watanabe; Masaki Fukata
Journal:  Nat Med       Date:  2014-12-08       Impact factor: 53.440

5.  Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic targeting of PSD-95.

Authors:  Jun Noritake; Yuko Fukata; Tsuyoshi Iwanaga; Naoki Hosomi; Ryouhei Tsutsumi; Naoto Matsuda; Hideki Tani; Hiroko Iwanari; Yasuhiro Mochizuki; Tatsuhiko Kodama; Yoshiharu Matsuura; David S Bredt; Takao Hamakubo; Masaki Fukata
Journal:  J Cell Biol       Date:  2009-07-13       Impact factor: 10.539

6.  G protein activation by the leukotriene B4 receptor dimer. Evidence for an absence of trans-activation.

Authors:  Marjorie Damian; Sophie Mary; Aimée Martin; Jean-Philippe Pin; Jean-Louis Banères
Journal:  J Biol Chem       Date:  2008-05-19       Impact factor: 5.157

7.  Expression of functional leukotriene B4 receptors on human airway smooth muscle cells.

Authors:  Satoko Watanabe; Akira Yamasaki; Kiyoshi Hashimoto; Yasushi Shigeoka; Hiroki Chikumi; Yasuyuki Hasegawa; Takashi Sumikawa; Miyako Takata; Ryota Okazaki; Masanari Watanabe; Tsuyoshi Yokogawa; Miki Yamamura; Tatsuya Hayabuchi; William T Gerthoffer; Andrew J Halayko; Eiji Shimizu
Journal:  J Allergy Clin Immunol       Date:  2009-05-27       Impact factor: 10.793

8.  A simple detection method for low-affinity membrane protein interactions by baculoviral display.

Authors:  Toshiko Sakihama; Takato Sato; Hiroko Iwanari; Toshio Kitamura; Shimon Sakaguchi; Tatsuhiko Kodama; Takao Hamakubo
Journal:  PLoS One       Date:  2008-12-24       Impact factor: 3.240

9.  High-titer preparation of Bombyx mori nucleopolyhedrovirus (BmNPV) displaying recombinant protein in silkworm larvae by size exclusion chromatography and its characterization.

Authors:  Tatsuya Kato; Suganthi Lavender Manoha; Shigeyasu Tanaka; Enoch Y Park
Journal:  BMC Biotechnol       Date:  2009-06-12       Impact factor: 2.563

Review 10.  Silkworm expression system as a platform technology in life science.

Authors:  Tatsuya Kato; Mizuho Kajikawa; Katsumi Maenaka; Enoch Y Park
Journal:  Appl Microbiol Biotechnol       Date:  2010-01       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.